Diaxonhit Receives Financing from Bpifrance for the Development of a Companion Diagnostic for a Therapeutic Vaccine Against AIDS

Financing of € 1 728 000 through both grants and reimbursable advances Development of a companion diagnostic for measuring response to the therapeutic vaccine Development of an early marker of disease progression April 28, 2014 Diaxonhit announced today that it was granted € 1,728,000 by Bpifrance, as part of its involvement in a research consortium led by InnaVirVax and funded under the …